Pharmacological Modulation of the Psychiatric Risk Factor FKBP51 Alters Efficiency of Common Antidepressant Drugs

por Pöhlmann, Max L., Häusl, Alexander S., Harbich, Daniela, Balsevich, Georgia, Engelhardt, Clara, Feng, Xixi, Breitsamer, Michaela, Hausch, Felix, Winter, Gerhard, Schmidt, Mathias V.
Publicado 2018

The stress regulator FKBP51: a novel and promising druggable target for the treatment of persistent pain states across sexes

por Maiarù, Maria, Morgan, Oakley B., Mao, Tianqi, Breitsamer, Michaela, Bamber, Harry, Pöhlmann, Max, Schmidt, Mathias V., Winter, Gerhard, Hausch, Felix, Géranton, Sandrine M.
Publicado 2018

Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function

por Balsevich, Georgia, Häusl, Alexander S., Meyer, Carola W., Karamihalev, Stoyo, Feng, Xixi, Pöhlmann, Max L., Dournes, Carine, Uribe-Marino, Andres, Santarelli, Sara, Labermaier, Christiana, Hafner, Kathrin, Mao, Tianqi, Breitsamer, Michaela, Theodoropoulou, Marily, Namendorf, Christian, Uhr, Manfred, Paez-Pereda, Marcelo, Winter, Gerhard, Hausch, Felix, Chen, Alon, Tschöp, Matthias H., Rein, Theo, Gassen, Nils C., Schmidt, Mathias V.
Publicado 2017